Safety Monitoring.

Keep safety always in sight.

“Rivia’s integrated safety enables us to detect early signals across datasets, generate recurring reports with ease, and take faster corrective actions while ensuring continuous safety profiling."

Henk Streefkerk

CEO, Drug Safety Officer, Omeicos Therapeutics

For Safety Science Teams

Integrated Safety Surveillance

Consolidate data from EDC, Central labs, safety databases and more for a comprehensive, integrated view of safety.

TEAE/SAE/AESI Assessments

Assess treatment-emergent, serious, or adverse events of special interest reliably across time periods and patient groups.

Subgroup Safety Analysis

Perform MedDRA-based queries to evaluate safety trends across patient subgroups.

Patient Narratives and causality assessment

Perform causality assessments effortlessly by asking your data the questions you need answers to, powered by Rivia Spark AI within the Patient Profile.

Consistent Safety Reporting

Generate reports for SRCs, DSURs, KOLs, PIs and others with ease.

Signal Evaluation and Reporting

Evaluate Dose Limited Toxicities, detect early safety signals, and produce consistent reports for SRCs, DSURs, and other regulatory needs.

Key Advantages

Proactive Risk Management

Detect safety issues early, enhancing patient safety and trial compliance.

Resolute Reporting

From due to done in minutes. Reduce the time for high-quality safety report preparation.

Continuous Profiling

Monitor safety data in real-time for ongoing safety oversight.

Multiple sources.

One verdict.

Rivia streamlines our decision-making process by providing visualizations that can be easily understood by key stakeholders like the board. This aids in rapid response and adjustments in our strategic approach.

Blanky Tu

Head of Clinical Operations Oncology, Alentis Therapeutics

"I think every medic in the clinical trial, and also clinical leads in trials, should use this kind of software to have a better overview of their data."

Jos G.A. Houbiers

Chief Medical Officer, Calypso Biotech

"Without Rivia, we would be very dependent on our CRO and biostatisticians for almost every little detail of what we're analyzing, and we'd be spending a lot of time merging Excel spreadsheets."

Chris Farina

CEO, Abcentra Therapeutics

Explore How Rivia Solves

Real-World Challenges